JP2011074007A - Sleep-improving agent, and method for evaluating the same - Google Patents

Sleep-improving agent, and method for evaluating the same Download PDF

Info

Publication number
JP2011074007A
JP2011074007A JP2009226553A JP2009226553A JP2011074007A JP 2011074007 A JP2011074007 A JP 2011074007A JP 2009226553 A JP2009226553 A JP 2009226553A JP 2009226553 A JP2009226553 A JP 2009226553A JP 2011074007 A JP2011074007 A JP 2011074007A
Authority
JP
Japan
Prior art keywords
sleep
improving agent
effect
agent
bathing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009226553A
Other languages
Japanese (ja)
Inventor
Mari Hagiwara
摩里 萩原
Masahito Saito
雅人 齋藤
Tetsuo Miyashita
哲郎 宮下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kracie Home Products Ltd
Original Assignee
Kracie Home Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kracie Home Products Ltd filed Critical Kracie Home Products Ltd
Priority to JP2009226553A priority Critical patent/JP2011074007A/en
Publication of JP2011074007A publication Critical patent/JP2011074007A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a sleep-inducing agent by the adjustment of a fragrance tone, having a sleep induction-improving effect and high sleep-inducing effect, and a method for evaluating the effects. <P>SOLUTION: This sleep-improving agent is provided by containing fruity floral-based fragrant components containing ≥1% α-damascone and γ-undecalactone in its fragrant composition as active ingredients, and its effect is evaluated by using a bath agent blended with the sleep-improving agent and measuring at least any one of sleep polysomnography (PSG) or epidermal temperature after bathing. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、睡眠改善剤及びその評価方法に関するものであり、詳細には、生活環境の変化とりわけ夜間の活動が増加し、昼夜の生活パターンが不規則になることによる睡眠障害に対し、特に特定の香料成分により、入眠の問題を改善する睡眠改善剤及びその評価方法に関するものである。 The present invention relates to a sleep-improving agent and a method for evaluating the same, and in particular, particularly for sleep disorders caused by changes in the living environment, in particular, increased nighttime activities and irregular day / night life patterns. It is related with the sleep improving agent which improves the problem of falling asleep, and its evaluation method.

ここ数年、会社や学校や家族などの人間関係、インターネット・メールの発達やAV化、OA化、IC化など社会環境の急速な変化により仕事でストレスを感じる人が約6割近くおり、メンタルヘルスに関しての対応が重要となってきている。またこのような生活環境の変化により、夜間の活動が増加し、昼夜の生活パターンが不規則になり睡眠障害による疾病が増加している。不眠の原因には様々なストレス社会の中で、様々な悩みごとや心配ごとにより、自律神経系、内分泌系、免疫系が低下した場合等が挙げられる。 In recent years, nearly 60% of people feel stressed at work due to rapid changes in the social environment, such as relationships between companies, schools and families, the development of Internet mail, AV, OA, and IC. Health response is becoming important. In addition, due to such changes in living environment, nighttime activities are increasing, daytime and nightlife patterns are irregular, and diseases caused by sleep disorders are increasing. Causes of insomnia include cases in which the autonomic nervous system, endocrine system, and immune system are lowered due to various concerns and concerns in various stress societies.

特に、近年のストレスの増大によって、鎮静効果を有する香料成分によってストレスを解消する方法が提唱されている。例えば、有効成分を人に対し経口的又は経皮的に投与する方法や、香料組成物を気化させてその蒸気を吸気させるアロマテラピー等は、古くから行われている。このような、心理的なストレスに関する悩みの対処法としては、鎮静効果がありストレスを緩和する精油としては、ベルガモット、ラベンダー、ゼラニウム、イランイラン、ローズ等が広く知られている。より具体的には、ベルガモットは伝承的に鏡静効果があると言われている香料成分であるしその評価の技術が提案されており(特許文献1)ビターオレンジ精油(特許文献2)やジャスミンラクトン(特許文献3)を鼻粘膜、口腔粘膜あるいは肺組織から吸収させることにより誘眠を促進させることが提案されている。また、セダーウッド油の低沸点成分(α−ピネン、α−セドレン、β−セドレン、カリオフィレン等)を鎮静用精油として使用することも提案されている(特許文献4)。 In particular, due to an increase in stress in recent years, a method for relieving stress with a fragrance component having a sedative effect has been proposed. For example, a method of orally or transdermally administering an active ingredient to a person, an aromatherapy that vaporizes a fragrance composition and inhales the vapor thereof, and the like have been performed for a long time. Bergamot, lavender, geranium, ylang-ylang, rose and the like are widely known as essential oils that have a sedative effect and relieve stress as a method of dealing with such psychological stress concerns. More specifically, bergamot is a fragrance ingredient that is traditionally said to have a mirror effect, and a technique for its evaluation has been proposed (Patent Document 1) Bitter Orange Essential Oil (Patent Document 2) and Jasmine. It has been proposed to promote arousal by absorbing lactone (Patent Document 3) from the nasal mucosa, oral mucosa or lung tissue. It has also been proposed to use low boiling components of cedarwood oil (α-pinene, α-cedrene, β-cedrene, caryophyllene, etc.) as essential oils for sedation (Patent Document 4).

しかし、これらの成分の鎮静効果は、学術的な評価結果によって判定されたものではなく、経験的な知識又は官能試験によって判定されたものである。今後香料の精神状態への影響を研究する上では、客観的で再現性のある評価方法が必要とされる。 However, the sedative effects of these components are not determined by academic evaluation results, but by empirical knowledge or sensory tests. In the future, objective and reproducible evaluation methods will be required to study the effects of fragrances on the mental state.

特許文献5及び非特許文献1においては、マスクを使用して評価対象化合物を施与し、入眠時及び睡眠時における心電図測定によって自律神経のバランスを測定する方法が記載されている。しかし、このような方法においてはマスクを使用するため、日常生活と離れた状況での試験であり、マスクを使用していることによるストレスが試験結果に影響を与える可能性が高い。なお、本発明に関連する背景技術としては、上記文献に加えて特許文献6〜8の技術が挙げられる。 In Patent Document 5 and Non-Patent Document 1, a method is described in which an evaluation target compound is applied using a mask, and the balance of the autonomic nerve is measured by electrocardiogram measurement during sleep onset and sleep. However, since the mask is used in such a method, the test is performed in a situation away from daily life, and the stress due to the use of the mask is likely to affect the test result. As background art related to the present invention, the techniques of Patent Documents 6 to 8 can be cited in addition to the above-mentioned documents.

これらを解決する方法として、芳香剤、入浴剤、アロマオイル、御香、スプレーなど香りやまたは色による精神的疲労回復、ストレスの軽減、リフレッシュ、気分転換などを目的として広く商品に応用される。最近は、植物精油によるリラックス作用などアロマテラピーやインドのアーユルベータなどの研究も盛んである。このような中で、特に入浴剤は簡易な方法で、精神的効果に関しても近年では脳波や唾液などの指標を用いた評価のほか、睡眠への効果に関しての研究も行なわれるようになってきた。 As a method for solving these problems, it is widely applied to products for the purpose of recovering mental fatigue, reducing stress, refreshing, changing mood, etc. by fragrance or color such as fragrance, bathing agent, aroma oil, incense and spray. Recently, researches on aromatherapy such as relaxation by plant essential oil and Ayurbeta in India are also active. Under such circumstances, bathing agents are a simple method, and mental effects have recently been evaluated using indicators such as brain waves and saliva, as well as research on effects on sleep. .

特開2007−159919JP2007-159919 特開平4−128234号公報Japanese Patent Laid-Open No. 4-128234 特開平6−40911号公報Japanese Patent Laid-Open No. 6-40911 特開平5−255688号公報JP-A-5-255688 国際公開第01/058435号パンフレットInternational Publication No. 01/058435 Pamphlet 特開2005−325070号公報JP 2005-325070 A 特開2006−062998号公報JP 2006-062998 A 特開2006−063063号公報JP 2006-063063 A 特開2007−197334号公報JP 2007-197334 A 特開2008−050352号公報JP 2008-0050352 A

Automatic Neuroscuence: Basic and Clinical 108(2003) 第79-86頁Automatic Neuroscuence: Basic and Clinical 108 (2003) pp. 79-86

本発明は、上記現状に鑑み、入眠改善効果を有し、高い睡眠誘導効果を有する香調での調整の睡眠改善剤及びその効果を評価する方法を提供することを目的とするものである。 In view of the above-mentioned present situation, the present invention has an object of providing a sleep improving agent for adjusting incense tone having a sleep improvement effect and having a high sleep induction effect, and a method for evaluating the effect.

本発明者らは、フルーティフローラル系香料成分が、入眠時に睡眠改善効果を有すること見出し、本発明を完成させた。すなわち、本発明はフルーティフローラル系香料成分を有効成分として含有することを特徴とする睡眠改善剤である。 The present inventors have found that a fruity floral fragrance component has a sleep improvement effect upon falling asleep, and have completed the present invention. That is, this invention is a sleep improving agent characterized by including a fruity floral fragrance | flavor component as an active ingredient.

本発明の評価方法は、上記睡眠改善剤を配合した入浴剤を使用し、入浴後の睡眠ポリソムノグラフィ(PSG)及び表皮温の少なくとも一方を測定することにより行うものである。 The evaluation method of the present invention is performed by measuring at least one of sleep polysomnography (PSG) and epidermis temperature after bathing, using a bath preparation containing the above sleep-improving agent.

本発明によれば、入眠改善効果を有し、高い睡眠誘導効果を有する香調での調整の睡眠改善剤及びその効果を評価する方法を提供できる。 ADVANTAGE OF THE INVENTION According to this invention, it has the sleep improvement effect and can provide the sleep improvement agent of adjustment with the incense tone which has a high sleep induction effect, and the method of evaluating the effect.

本発明の睡眠改善剤の一実施形態における表皮温の遠位(右足部)と近位(左胸部)の差について経時変化を比較した結果を示すグラフである。It is a graph which shows the result of having compared a time-dependent change about the difference of distal (right leg | foot part) and proximal (left chest part) of epidermis temperature in one Embodiment of the sleep improving agent of this invention.

以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.

本発明の睡眠改善剤に配合するフルーティフローラル系香料としては、α−ダマスコン(α-Damascone)及びγ−ウンデカラクトン(γ-Undecalactone)を香料組成中1%以上含むことが必須である。その他のフルーティフローラル系香料構成成分としてリモネン(Limonene)、リナロ−ル(Linalool)、エチルブチレート(Ethyl Butylate)、フェニルエチルアルコール(Phenylethyl alcohol)、ゲラニオール(Geraniol)、シトロネロール(Citronellol)、ヘキシルアセテート(Hexyl acetate)、ベンズアルデヒド(Benzaldehyde)、ヘディオン(Hedione)、イソイースーパー(Iso E super)及びガラクソライド(Galaxolide)が挙げられ、これらから任意に1種または2種以上を配合することが可能であり、配合量もα−ダマスコン(α-Damascone)及びγ−ウンデカラクトン(γ-Undecalactone)の効果を阻害しない範囲で特に制限はない。 As a fruity floral fragrance | flavor mix | blended with the sleep improving agent of this invention, it is essential to contain 1% or more of (alpha) -damascon ((alpha) -Damascone) and (gamma) -undecalactone ((gamma) -Undecalactone) in a fragrance | flavor composition. Other fruity floral fragrance components include limonene, linalool, ethyl butylate, phenylethyl alcohol, geraniol, citronellol, hexyl acetate ( Hexyl acetate, Benzaldehyde, Hedione, Iso E super and Galaxolide can be included, and one or more can be added arbitrarily from these, The blending amount is not particularly limited as long as the effects of α-Damascone and γ-Undecalactone are not inhibited.

本発明の睡眠改善剤の評価方法は、上記フルーティフローラル系香料を有効成分として配
合した入浴剤を使用し、入浴後の睡眠ポリソムノグラフィ(PSG)及び表皮温の少なくとも一方を測定することにより睡眠改善効果を評価するものである。
The method for evaluating a sleep-improving agent of the present invention uses a bathing agent containing the fruity floral fragrance as an active ingredient, and measures at least one of sleep polysomnography (PSG) and epidermal temperature after bathing. This is to evaluate the sleep improvement effect.

以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。睡眠効果の測定方法は、本発明においては、以下の測定法によって確認することができる。なお、下記の例において特に明記のない場合は、組成の「%」は質量%である。 EXAMPLES Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example. In the present invention, the sleep effect measurement method can be confirmed by the following measurement method. In the following examples, unless otherwise specified, “%” of the composition is mass%.

[実施例、比較例]
表1に記載の香料にて試料を調製し、下記方法で入眠効果を評価した。対象者は同意の得られた健常女性7名とし、フルーティフローラル系香料を賦香した乳液タイプ入浴剤サンプル(実施例)および、香料を賦香しない対照サンプル(比較例)を用いた。本実験で用いたフルーティフローラル系香料の組成を表2に示す。α−ダマスコン(α-Damascone)1%、γ−ウンデカラクトン(γ-Undecalactone)1%を含み、その他の成分としてリモネン(Limonene)、リナロ−ル(Linalool)、エチルブチレート(Ethyl Butylate)、フェニルエチルアルコール(Phenylethyl alcohol)、ゲラニオール(Geraniol)、シトロネロール(Citronellol)、ヘキシルアセテート(Hexyl acetate)、ベンズアルデヒド(Benzaldehyde)、ヘディオン(Hedione)、イソイースーパー(Iso E super)及びガラクソライド(Galaxolide)等を含んだものをフルーティフローラル香料として評価した。
[Examples and Comparative Examples]
Samples were prepared with the fragrances listed in Table 1, and the sleep asleep effect was evaluated by the following method. The subjects were seven healthy women with consent, and used an emulsion type bath preparation sample (Example) in which a fruity floral fragrance was added and a control sample (Comparative Example) in which no fragrance was added. Table 2 shows the composition of the fruity floral fragrance used in this experiment. It contains 1% α-Damascone and 1% γ-Undecalactone, and other components include Limonene, Linalool, Ethyl Butylate, Phenylethyl alcohol, Geraniol, Citronellol, Hexyl acetate, Benzaldehyde, Hedione, Iso E super, Galaxolide, etc. The inclusion was evaluated as a fruity floral fragrance.

Figure 2011074007
Figure 2011074007

Figure 2011074007
Figure 2011074007

実験は対象者1人に対し、順応夜1夜とそれに引き続くサンプル使用夜2夜の連続計3夜行い、サンプル使用夜についてはクロスオーバー法を用い順序効果を考慮した上で、フルーティフローラル系香料0.95%配合した入浴剤(実施例)および無香料入浴剤(比較例)のいずれかを割り付けた。なお対象者は過去に重篤な身体的既往がなく、睡眠質問表を用いて現在の睡眠習慣に大きな問題がないことを確認した。また実験期間中、アルコール飲料、コーヒーや茶葉抽出物などのカフェイン含有飲料の摂取、バナナや柑橘類などのカテコラミン含有飲食物の摂取、過度の運動、午睡を禁止した。また実験の3夜は曜日効果を考慮し、全例とも平日の同一曜日になるように実験日程を調整した。 The experiment was conducted for one subject, 3 nights in total, one night of adaptation followed by 2 nights of sample use. For the nights of sample use, the crossover method was used and the order effect was taken into account, and a fruity floral fragrance was used. Either a bathing agent (Example) containing 0.95% or an unscented bathing agent (Comparative Example) was assigned. In addition, the subject confirmed that there was no serious physical history in the past and that there was no big problem in the present sleep habit using the sleep questionnaire. During the experiment, alcoholic beverages, caffeine-containing beverages such as coffee and tea leaf extracts, catecholamine-containing foods and beverages such as bananas and citrus fruits, excessive exercise, and nap were prohibited. In addition, considering the effect of the day of the week on the third night of the experiment, the experiment schedule was adjusted so that all the cases were on the same day of the week.

19時までに夕食を摂った後、20時より15分間、表1の処方の入浴剤を使用し入浴を行なった。湯温40℃、入浴剤は200Lの水道水温水に対して40mLとなるよう濃度を調整した。 After having dinner by 19 o'clock, bathing was performed for 15 minutes from 20 o'clock using the bathing agent of the prescription in Table 1. The hot water temperature was 40 ° C., and the bathing agent was adjusted to a concentration of 40 mL with respect to 200 L of tap water.

20:30から22:00までの間に終夜睡眠ポリソムノグラフィ(PSG)記録用の電極を装着し、PSG記録装置に接続して生理学的なキャリブレーションを行なった。22:55にはベッド上に臥床してPSG測定開始準備状態に入り、23:00に消灯して照度5lux以下の状態で翌朝7:00までPSG記録を行なった。右足の第3、4趾間および左胸部には表皮温測定用プローブを装着したうえ、長時間携帯用体温ロガーを用いて表皮温の測定を行なった。測定については順応夜を含み、入浴など行動ロガーが破損する危険のある場合を除き24時間の連続測定を行い3日間分を記録した。表皮温測定については20:00から翌朝7:00までを1日分の記録とし、3夜にわたり連続的に測定した。起床時刻は7:00とし、頭皮に付着した電極ペースト除去などのためのシャワー浴を行い、朝食を摂った後に解散し、日中は通常の生活を続けるよう指示した。 Between 20:30 and 22:00, electrodes for overnight polysomnography (PSG) recording were mounted and connected to a PSG recording apparatus for physiological calibration. At 22:55, a bed was placed on the bed and a PSG measurement start preparation state was entered. At 23:00, the PSG recording was performed until 7:00 the next morning in a state where the illuminance was 5 lux or less. An epidermis temperature measurement probe was attached to the third and fourth ribs of the right foot and the left chest, and the epidermis temperature was measured using a portable body temperature logger for a long time. The measurement included adaptation nights, and 24 hours of continuous measurement was performed and recorded for 3 days, except when there was a risk of damage to the behavior logger such as bathing. The epidermal temperature was measured from 20:00 to 7:00 the next morning, and recorded continuously for 3 nights. The wake-up time was 7:00, a shower bath was taken to remove the electrode paste attached to the scalp, etc., and after having breakfast, it was dissolved, and it was instructed to continue normal life during the day.

データ解析は順応夜を除く2夜について、実施例夜と比較例夜の差について比較し検討を行った。PSGの睡眠段階判定はRechtschaffen & Kales(1968)の方法によって行い、睡眠時間(SPT)、睡眠潜時(SL)、睡眠段階1−4およびレムの各睡眠潜時(
S1−S4,LR)深睡眠潜時(SWSL)レム睡眠潜時(RL)、睡眠効率(SE)、覚醒、睡眠段階1−4、レムの各段階の時間(Wm,1m−4m,Rm)、および各睡眠段階の比率(Wr,1r−4r,Rr)を算出した。
Data analysis was conducted by comparing the difference between Example night and Comparative example night for two nights excluding adaptation night. The sleep stage determination of PSG is performed by the method of Rechtschaffen & Kales (1968). Sleep time (SPT), sleep latency (SL), sleep stages 1-4 and REM sleep latency (
S1-S4, LR) Deep sleep latency (SWSL) REM sleep latency (RL), sleep efficiency (SE), awakening, sleep stage 1-4, time of each stage of REM (Wm, 1m-4m, Rm) And the ratio of each sleep stage (Wr, 1r-4r, Rr).

睡眠3分法(就床時から150分毎に解析を行なう方法)による睡眠ステージの結果を表3に示す。 Table 3 shows the results of the sleep stage according to the sleep 3-minute method (method of analyzing every 150 minutes from bedtime).

Figure 2011074007
Figure 2011074007

睡眠3分法を用いた解析を行なった結果、23:00−1:30でのS3,S4の出現率およびS4の出現率について、実施例が比較例に比べ高い値を示した。表皮温の遠位(右足部)と近位(左胸部)の差について経時変化を比較した結果、睡眠初期において、実施例が比較例と比較し有意に高い値を示した。(図1に示す。) As a result of the analysis using the sleep trisection method, the example showed a higher value than the comparative example with respect to the appearance rate of S3 and S4 and the appearance rate of S4 at 23: 00-1: 30. As a result of comparing temporal changes in the difference between the distal (right foot) and proximal (left chest) of the epidermal temperature, the Example showed a significantly higher value in the early stage of sleep than the Comparative Example. (Shown in FIG. 1)

睡眠3分法により、睡眠導入期における実施例のS3+S4の出現率およびS4の出現率が比較例よりも多い値にあったことから、香料を配合した入浴剤浴によって睡眠状態が改善されたことがわかった。表皮膚温は表皮毛細血管の収縮および拡張が反映された結果で、さらにこれは自律神経系の活動の変化が反映した結果である。今回の結果では実施例で比較例よりも入眠後に遠位皮膚温と近位皮膚温の差が大きく、入眠時には遠位皮膚温と近位皮膚温の開きが大きくなることも知られている。よって、フルーティフローラル香料を配合した入浴剤を使用した入浴が、入眠過程での睡眠状態によい影響を与えたことは明白である。 By the sleep 3-minute method, the appearance rate of S3 + S4 and the appearance rate of S4 of the example in the sleep induction period were higher than those of the comparative example, so that the sleep state was improved by the bath agent bath containing the fragrance. I understood. The surface skin temperature is a result of reflecting the contraction and dilation of epidermal capillaries, and this is a result of reflecting changes in the activity of the autonomic nervous system. It is also known that the difference between the distal skin temperature and the proximal skin temperature is greater after sleep on the Example than the comparative example, and the difference between the distal skin temperature and the proximal skin temperature is greater during sleep on the result. Therefore, it is clear that bathing using a bathing agent blended with a fruity floral fragrance has a positive effect on the sleep state during the sleeping process.

1 実施例
2 比較例
1 Example 2 Comparative example

Claims (2)

α−ダマスコン(α-Damascone)及びγ−ウンデカラクトン(γ-Undecalactone)を香料組成中1%以上含むフルーティフローラル系香料成分を有効成分として含有することを特徴とする睡眠改善剤。 A sleep-improving agent comprising, as an active ingredient, a fruity floral fragrance component containing 1% or more of α-Damascone and γ-Undecalactone in the fragrance composition. 請求項1記載の睡眠改善剤を配合した入浴剤を使用し、入浴後の睡眠ポリソムノグラフィ(PSG)及び表皮温の少なくとも一方を測定することにより睡眠改善効果を評価することを特徴とする睡眠改善剤の評価方法。 The bath improving agent according to claim 1 is used, and the sleep improving effect is evaluated by measuring at least one of sleep polysomnography (PSG) and epidermis temperature after bathing. Evaluation method of sleep improving agent.
JP2009226553A 2009-09-30 2009-09-30 Sleep-improving agent, and method for evaluating the same Pending JP2011074007A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009226553A JP2011074007A (en) 2009-09-30 2009-09-30 Sleep-improving agent, and method for evaluating the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009226553A JP2011074007A (en) 2009-09-30 2009-09-30 Sleep-improving agent, and method for evaluating the same

Publications (1)

Publication Number Publication Date
JP2011074007A true JP2011074007A (en) 2011-04-14

Family

ID=44018370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009226553A Pending JP2011074007A (en) 2009-09-30 2009-09-30 Sleep-improving agent, and method for evaluating the same

Country Status (1)

Country Link
JP (1) JP2011074007A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180064146A (en) * 2016-12-05 2018-06-14 주식회사 엘지생활건강 Perfume composition representing the fragrance of Lilium hansonii Leichtlin
WO2020004182A1 (en) * 2018-06-25 2020-01-02 高砂香料工業株式会社 Sleep-enhancing agent
WO2023282160A1 (en) * 2021-07-07 2023-01-12 高砂香料工業株式会社 Perfume composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180064146A (en) * 2016-12-05 2018-06-14 주식회사 엘지생활건강 Perfume composition representing the fragrance of Lilium hansonii Leichtlin
KR101881668B1 (en) * 2016-12-05 2018-07-24 주식회사 엘지생활건강 Perfume composition representing the fragrance of Lilium hansonii Leichtlin
WO2020004182A1 (en) * 2018-06-25 2020-01-02 高砂香料工業株式会社 Sleep-enhancing agent
JPWO2020004182A1 (en) * 2018-06-25 2021-08-19 高砂香料工業株式会社 Sleep improver
WO2023282160A1 (en) * 2021-07-07 2023-01-12 高砂香料工業株式会社 Perfume composition

Similar Documents

Publication Publication Date Title
Terzano et al. CAP variables and arousals as sleep electroencephalogram markers for primary insomnia
Sayorwan et al. Effects of inhaled rosemary oil on subjective feelings and activities of the nervous system
JP5007833B2 (en) Autonomic nerve regulator
TWI432226B (en) Fragrance composition having good sleep-inducing effect
WO2012165831A2 (en) Aromatic composition having stress-relieving and relaxing effects and cosmetic composition containing same
JP2015038131A (en) Oregano extract for alertness
Schredl et al. The effect of rivastigmine on sleep in elderly healthy subjects
Takeda et al. Differences between the physiologic and psychologic effects of aromatherapy body treatment
JP2012521416A (en) Fragrance and cosmetic composition having stress relieving and sedative effects
KR101074955B1 (en) Perfume composition having aromatherapic effect
JP2011074007A (en) Sleep-improving agent, and method for evaluating the same
JP5558016B2 (en) Circadian rhythm regulator
WO2020004182A1 (en) Sleep-enhancing agent
JP2018179603A (en) Estimation method of physiology and psychological effects of scent using psychology, nerve, endocrine, and immunity index
JP2015081227A (en) Sleep improvement agent
KR102455783B1 (en) Natural essential oil composition with excellent sleep effect and Cosmetic composition comprising the same
JP5019016B2 (en) Sleep improver and fragrance preparation
WO2005049773A1 (en) Method of multidimensionally evaluating smell and fragrance promoting nerve activity
Yamagishi et al. Sleep-improving effects of the aromatic compound heliotropin
KR20120065813A (en) Fragrance composition for providing sedative effect and leading sound sleep
Schwartz et al. Band-specific electroencephalogram and brain cooling abnormalities during NREM sleep in patients with winter depression
JP2020516643A (en) Compositions containing essential oils for topical use
JP2011037721A (en) Skin care preparation for external use exhibiting sleep-improving action
KR20190024623A (en) Essential oil composition for psychological stability including a palmarosa oil and method for verifying fragrance efficacy of the essential oil composition for psychological stability using multi-modal bio-signal measurement technology
CN105288421B (en) A kind of inducing resuscitation that clears away heart-fire rouses oneself mood, the herbal composite that decompression is recovered from fatigue